Cite
Image-Guided Radiotherapy for Prostate Cancer: A Prospective Trial of Concomitant Boost Using Indium-111–Capromab Pendetide (ProstaScint) Imaging
MLA
Wong, William W., et al. “Image-Guided Radiotherapy for Prostate Cancer: A Prospective Trial of Concomitant Boost Using Indium-111–Capromab Pendetide (ProstaScint) Imaging.” International Journal of Radiation Oncology, Biology, Physics, vol. 81, no. 4, Nov. 2011, pp. e423–29. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2011.01.048.
APA
Wong, W. W., Schild, S. E., Vora, S. A., Ezzell, G. A., Nguyen, B. D., Ram, P. C., & Roarke, M. C. (2011). Image-Guided Radiotherapy for Prostate Cancer: A Prospective Trial of Concomitant Boost Using Indium-111–Capromab Pendetide (ProstaScint) Imaging. International Journal of Radiation Oncology, Biology, Physics, 81(4), e423–e429. https://doi.org/10.1016/j.ijrobp.2011.01.048
Chicago
Wong, William W., Steven E. Schild, Sujay A. Vora, Gary A. Ezzell, Ba D. Nguyen, Panol C. Ram, and Michael C. Roarke. 2011. “Image-Guided Radiotherapy for Prostate Cancer: A Prospective Trial of Concomitant Boost Using Indium-111–Capromab Pendetide (ProstaScint) Imaging.” International Journal of Radiation Oncology, Biology, Physics 81 (4): e423–29. doi:10.1016/j.ijrobp.2011.01.048.